Moderna Receives Refusal-to-File Letter from the U.S. Food and Drug Administration for Its Investigational Seasonal Influenza Vaccine, mRNA-1010

Refusal to review the submission is inconsistent with feedback at pre-Phase 3 and pre-submission consultations; Moderna ...
Fierce Biotech

Moderna hit with FDA refusal-to-file letter for mRNA flu shot, issues sharp rebuke of agency's rationale

During the first year of the Trump administration, signs of an anti-mRNA slant within the FDA and the Department of Health ...
BioSpace

Sanofi Moves Away From mRNA Flu Vaccine as CEO Projects Confidence

Despite Sanofi CEO Paul Hudson’s confidence in vaccines, the French pharma has cut at least one mRNA flu shot program.
KRQE Blogs

FDA refuses Moderna application for a new mRNA flu vaccine

WASHINGTON (AP) — The U.S. Food and Drug Administration is refusing to consider Moderna’s application for a new flu vaccine ...
The Independent on MSN

First mRNA vaccine to be produced in UK approved

First mRNA vaccine to be produced in UK approved by regulators - The Moderna Innovation and Technology Centre will make ...